48,436
edits
Difference between revisions of "Pathology for medical students"
Jump to navigation
Jump to search
→Techniques
| Line 63: | Line 63: | ||
*Targeted therapies/molecular testing: | *Targeted therapies/molecular testing: | ||
**Receptors in breast cancer (ER, PR, HER2). | **Receptors in breast cancer (ER, PR, HER2). | ||
**Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], PD-L1, [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]). | **Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], [[PD-L1]], [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]). | ||
**BRAF testing in [[malignant melanoma]]. | **BRAF testing in [[malignant melanoma]]. | ||
**[[Microsatellite instability in colorectal cancer|MSI testing]] in [[colorectal cancer]]. | **[[Microsatellite instability in colorectal cancer|MSI testing]] in [[colorectal cancer]]. | ||